| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039943823 |
| P356 | DOI | 10.1054/BJOC.2001.1871 |
| P8608 | Fatcat ID | release_65l63d6j6nc3bgxo2fz5hrdbfm |
| P932 | PMC publication ID | 2364048 |
| P698 | PubMed publication ID | 11461068 |
| P5875 | ResearchGate publication ID | 11881126 |
| P50 | author | Per Eystein Lønning | Q11995192 |
| P2093 | author name string | J M Holly | |
| J Geisler | |||
| S I Helle | |||
| B Leirvaag | |||
| G B Anker | |||
| P2860 | cites work | Insulin-like growth factors and their binding proteins: biological actions | Q28301853 |
| Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis | Q33698335 | ||
| Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer | Q34275378 | ||
| Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice | Q34578428 | ||
| Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women | Q35013234 | ||
| Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study | Q36114875 | ||
| Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations | Q38667678 | ||
| Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line | Q40884659 | ||
| Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells | Q40988807 | ||
| Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells | Q41291278 | ||
| Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media | Q41519206 | ||
| Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells | Q41711044 | ||
| Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluids | Q41979939 | ||
| Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol | Q42656683 | ||
| The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture | Q42803245 | ||
| Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex | Q43503837 | ||
| Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. | Q44833988 | ||
| Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis | Q46096779 | ||
| Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients | Q46100404 | ||
| Insulin-Like Growth Factor Binding Proteins in Maternal Serum Throughout Gestation and in the Puerperium: Effects of a Pregnancy-Associated Serum Protease Activity* | Q46189339 | ||
| A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. | Q47704337 | ||
| Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. | Q51578107 | ||
| Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients. | Q51582968 | ||
| The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery. | Q51583397 | ||
| Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients | Q51604520 | ||
| Insulin-like growth factor binding proteins (IGFBPs) in acromegaly | Q51609665 | ||
| Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. | Q52507340 | ||
| Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. | Q52523736 | ||
| Diethylstilbestrol: Recommended Dosages for Different Categories of Breast Cancer Patients | Q56213283 | ||
| Circulating concentrations of insulin-like growth factor I and risk of breast cancer | Q57751183 | ||
| Diethylstilbestrol: recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cancer Group | Q67021301 | ||
| Effects of tamoxifen on cardiovascular risk factors in postmenopausal women | Q68060159 | ||
| Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies | Q68962393 | ||
| Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine | Q69917003 | ||
| In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen | Q70646161 | ||
| Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients | Q71513576 | ||
| Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma | Q71544505 | ||
| Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity | Q71703964 | ||
| Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer | Q71886496 | ||
| Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen | Q72086641 | ||
| Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells | Q72524963 | ||
| Differential regulation of insulin-like growth factor-binding protein-3 protease activity in MCF-7 breast cancer cells by estrogen and transforming growth factor-beta1 | Q74244296 | ||
| Influence of Synthetic Oestrogens on Advanced Malignant Disease | Q84940700 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| metastatic breast cancer | Q12859063 | ||
| P304 | page(s) | 147-51 | |
| P577 | publication date | 2001-07-20 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer | |
| P478 | volume | 85 |
| Q44191663 | Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor |
| Q44543123 | Increase of free insulin-like growth factor-1 in normal human breast in vivo late in the menstrual cycle |
| Q34330521 | Insulin-like growth factors and neoplasia. |
| Q35197911 | Serum levels of insulin-like growth factor I and its binding proteins in health and disease |
| Q35612304 | The insulin-like growth factor system in advanced breast cancer |
Search more.